Conference Details: The key intention of ICVI is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. In addition this gathering will help the delegates to establish research or business relations as well as to find international linkage for future collaborations in their career path. We hope that ICVI outcome will lead to significant contributions to the knowledge base in these up-to-date scientific fields in scope.
Type: Conference
Status: Active
Venue: Leuven,Belgium
Conference Date: 2024-08-24 To 2024-08-24
Deadline for Abstract/Paper Submissions: 2024-08-02
Conference Category: Vaccines
Conference Topic: Gastroenterology, Sleep Disorders, Men's Health, Alternative Health, Health, Women's Health, Oral Health, Dentistry, Medical ethics, Asthma, Skin Conditions & Beauty, Disability and Rehabilitation, Neurology, Cancer, Thyroid & Metabolism Conditions, Food Safety, Nutrition and Dietetics, Cholesterol, Gerontology, Palliative Care, Depression, Infectious diseases, Brain & Nervous System, Public Health, Digestive Disorders, Medicine and Medical Science, Children's Health, Surgery, Eye Health, Nursing, Diabetes, Headaches & Migraines, Oncology, Ear Nose and Throat Conditions, Heart Health, Psychiatry, First Aid & Emergencies, Pain Management, Radiology, Healthy Living, Sexual Health, Social Work, Infections, Blood Pressure, Cardiology, Mental Health, Cold & Flu, Dermatology, Osteoporosis, Heartburn & GERD, Family Medicine, Pregnancy, Lung Disease & Respiratory Health, Pharmacy, Ophthalmology, Biophysics, Obesity, Bioethics, Vaccines, Biomedicine, Hepatitis, Urology, Radiography, Autism, Orthopedics, Anaesthesia, Gynecology, Allergy, Medical Statistics, Ent, Medical Imaging, Microbiology, Immune Systems, Pathology, Hygiene, Epidemiology, Behavioral Medicine, Neuroscience, Forensic, Pediatric, Ultrasound, Cell Sciences.
Organize By: Japanese Society for Academic Research and Publication
Website: Click Here
Email Id: [email protected]